Gene · 171221
DNAJB1P1: DNAJB1 pseudogene 1
12 sourcesgene-search-2026-11-11-0.2.0
Download JSON
Cite this record
ConductScience Library. DNAJB1P1: DNAJB1 pseudogene 1. Genes, record 171221. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/171221
On this page
Gene
Proteins0
Reviewed human proteins whose Swiss-Prot entry states the gene.
None in this release.
Patents0
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
None in this release.
Drugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants1,959
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | DNAJB1P1 papers | Newest fiscal year |
|---|---|---|---|
| P30CA008748 | Cancer Center Support Grant | 18 | 2025 |
| R01NS059690 | Molecular Chaperones and Small Molecules | 15 | 2025 |
| ZIASC010074 | HSP90 and HSP70 Chaperone Proteins and Interactors in Cellular Signal Transduction | 10 | 2025 |
| ZIABC011032 | Post-translational modifications of Hsp90 | 8 | 2025 |
| R01HL095524 | Modulation of Lung Disease by Genetic/Epigenetic Profiling | 7 | 2025 |
| R01GM098592 | Structural and functional studies of Hsp70/Hsp110 molecular chaperones | 6 | 2025 |
| P30CA016058 | Cancer Center Support Grant | 5 | 2025 |
| P30DK026743 | UCSF Liver Center | 5 | 2025 |
| K24AR073317 | Clinical and Translational studies in muscle disease | 4 | 2025 |
| P30CA010815 | Consolidated Basic Cancer Research Program | 4 | 2025 |
1 to 10 of 1,959Source NIH's project files
See all 1,959 nih grantsPapers3,230
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Combined Circulating miR-17-5p and Heat Shock Proteins as Diagnostic Biomarkers for Colorectal Cancer Progression. | Asian Pac J Cancer Prev | 2026 | 42808411 | PubTator, text mining | PubMed |
| Variable phenotypic manifestations of two splice-site variants in DNAJB2: insights from two families and a systematic review. | J Hum Genet | 2026 | 42806108 | PubTator, text mining | PubMed |
| Heat Shock Proteins in Cancer: Mechanisms and Therapeutic Targeting. | MedComm (2020) | 2026 | 42732222 | PubTator, text mining | PubMed |
| Integrated Analyses of mRNA and microRNA Regulatory Networks at Different Soil Moisture in Tropical Earthworm Eudrilus eugeniae. | Biology (Basel) | 2026 | 42651691 | PubTator, text mining | PubMed |
| The Potential Targets of Novel Triazine Derivatives on Mechanisms of Apoptosis, Regulation of the Cell Cycle, and Endoplasmic Reticulum Stress Pathways in Human Lung Cancer. | Arch Pharm (Weinheim) | 2026 | 42397105 | PubTator, text mining | PubMed |
| Codon usage bias and molecular evolution of Dnajc15 across avian lineages. | Front Genet | 2026 | 42376278 | PubTator, text mining | PubMed |
| Heat Shock Proteins in Medically Relevant Fungal Pathogens: From Molecular Chaperones to Virulence Factors and Therapeutic Targets. | J Fungi (Basel) | 2026 | 42346544 | PubTator, text mining | PubMed |
| FKBP8 connects the Hsp70-Hsp90 chaperone machinery to the folding of membrane proteins. | Nat Commun | 2026 | 42321214 | PubTator, text mining | PubMed |
| Heat shock protein-mediated remodeling of the bone immune microenvironment: mechanisms and precision therapeutic strategies for osteoporosis. | J Transl Med | 2026 | 42260517 | PubTator, text mining | PubMed |
| DNAJC9 promotes cervical cancer cell proliferation by regulating GLI1 expression. | Acta Biochim Biophys Sin (Shanghai) | 2026 | 42185231 | PubTator, text mining | PubMed |
1 to 10 of 3,230
See all 3,230 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/171221
GET https://conductscience.org/api/genes/v1/171221/grants?page=2